168 related articles for article (PubMed ID: 19361150)
21. Effects of acute angiotensin II type 1 receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patients with heart failure.
Goodfield NE; Newby DE; Ludlam CA; Flapan AD
Circulation; 1999 Jun; 99(23):2983-5. PubMed ID: 10368114
[TBL] [Abstract][Full Text] [Related]
22. Regional cardiac expression and concentration of natriuretic peptides in patients with severe chronic heart failure.
Hystad ME; Geiran OR; Attramadal H; Spurkland A; Vege A ; Simonsen S; Hall C
Acta Physiol Scand; 2001 Apr; 171(4):395-403. PubMed ID: 11421854
[TBL] [Abstract][Full Text] [Related]
23. Cardiac natriuretic peptides and continuously monitored atrial pressures during chronic rapid pacing in pigs.
Qi W; Kjekshus H; Klinge R; Kjekshus JK; Hall C
Acta Physiol Scand; 2000 Jun; 169(2):95-102. PubMed ID: 10848639
[TBL] [Abstract][Full Text] [Related]
24. How does treatment influence endocrine mechanisms in acute severe heart failure? Effects on cardiac natriuretic peptides, the renin system, neuropeptide Y and catecholamines.
Missouris CG; Grouzmann E; Buckley MG; Barron J; MacGregor GA; Singer DR
Clin Sci (Lond); 1998 Jun; 94(6):591-9. PubMed ID: 9854456
[TBL] [Abstract][Full Text] [Related]
25. [Atrial natriuretic factor and brain natriuretic peptide. Variations in elderly subjects with heart failure].
Tissandier O; Nasr A; Rainfray M; Hamon-Vilcot B; Piette F
Presse Med; 1995 Dec; 24(38):1837-41. PubMed ID: 8545437
[TBL] [Abstract][Full Text] [Related]
26. Deconvolution analysis of cardiac natriuretic peptides during acute volume overload.
Pemberton CJ; Johnson ML; Yandle TG; Espiner EA
Hypertension; 2000 Sep; 36(3):355-9. PubMed ID: 10988264
[TBL] [Abstract][Full Text] [Related]
27. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction.
Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL
Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235
[TBL] [Abstract][Full Text] [Related]
28. Beneficial neurohormonal profile of spironolactone in severe congestive heart failure: results from the RALES neurohormonal substudy.
Rousseau MF; Gurné O; Duprez D; Van Mieghem W; Robert A; Ahn S; Galanti L; Ketelslegers JM;
J Am Coll Cardiol; 2002 Nov; 40(9):1596-601. PubMed ID: 12427411
[TBL] [Abstract][Full Text] [Related]
29. ANP and BNP responses to dehydration in the one-humped camel and effects of blocking the renin-angiotensin system.
Adem A; Al Haj M; Benedict S; Yasin J; Nagelkerke N; Nyberg F; Yandle TG; Frampton CM; Lewis LK; Nicholls MG; Kazzam E
PLoS One; 2013; 8(3):e57806. PubMed ID: 23516417
[TBL] [Abstract][Full Text] [Related]
30. Plasma proatrial natriuretic factor is predictive of clinical status in patients with congestive heart failure.
Dickstein K; Larsen AI; Bonarjee V; Thoresen M; Aarsland T; Hall C
Am J Cardiol; 1995 Oct; 76(10):679-83. PubMed ID: 7572624
[TBL] [Abstract][Full Text] [Related]
31. Endothelin-1 is involved in stretch-induced early activation of B-type natriuretic peptide gene expression in atrial but not in ventricular myocytes: acute effects of mixed ET(A)/ET(B) and AT1 receptor antagonists in vivo and in vitro.
Magga J; Vuolteenaho O; Marttila M; Ruskoaho H
Circulation; 1997 Nov; 96(9):3053-62. PubMed ID: 9386175
[TBL] [Abstract][Full Text] [Related]
32. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure.
Mair J; Hammerer-Lercher A; Puschendorf B
Clin Chem Lab Med; 2001 Jul; 39(7):571-88. PubMed ID: 11522102
[TBL] [Abstract][Full Text] [Related]
33. Increased atrial natriuretic factor prohormone peptides with aging in the heart, but not in lung, liver, or intestine.
Giordano AT; Raska-Emery P; Montgomery MR; Vesely DL
Growth Dev Aging; 1993; 57(2):111-20. PubMed ID: 8495993
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis of heart failure using urinary natriuretic peptides.
Ng LL; Geeranavar S; Jennings SC; Loke I; O'Brien RJ
Clin Sci (Lond); 2004 Feb; 106(2):129-33. PubMed ID: 13678415
[TBL] [Abstract][Full Text] [Related]
35. Plasma and cardiac tissue atrial and brain natriuretic peptides in experimental heart failure.
Moe GW; Grima EA; Wong NL; Howard RJ; Armstrong PW
J Am Coll Cardiol; 1996 Mar; 27(3):720-7. PubMed ID: 8606288
[TBL] [Abstract][Full Text] [Related]
36. Cardiac peptides differ in their response to exercise. Implications for patients with heart failure in clinical practice.
Wijbenga JA; Balk AH; Boomsma F; Man in 't Veld AJ; Hall C
Eur Heart J; 1999 Oct; 20(19):1424-8. PubMed ID: 10487803
[TBL] [Abstract][Full Text] [Related]
37. Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives.
Kjaer A; Hesse B
Clin Physiol; 2001 Nov; 21(6):661-72. PubMed ID: 11722473
[TBL] [Abstract][Full Text] [Related]
38. Differential responses of plasma atrial and brain natriuretic peptides to acute alteration in atrial pressure in pigs.
Qi W; Kjekshus J; Hall C
Scand J Clin Lab Invest; 2000 Feb; 60(1):55-63. PubMed ID: 10757454
[TBL] [Abstract][Full Text] [Related]
39. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction.
Richards AM; Nicholls MG; Yandle TG; Frampton C; Espiner EA; Turner JG; Buttimore RC; Lainchbury JG; Elliott JM; Ikram H; Crozier IG; Smyth DW
Circulation; 1998 May; 97(19):1921-9. PubMed ID: 9609085
[TBL] [Abstract][Full Text] [Related]
40. B-type natriuretic peptide in ischemic heart disease.
Deo R; de Lemos JA
Curr Cardiol Rep; 2003 Jul; 5(4):271-7. PubMed ID: 12801444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
